Everolimus Tablet, For Suspension
Product Images NDC 70377-090

Product Visual Gallery

This gallery contains 41 technical images submitted to the FDA as part of the official labeling for Everolimus (NDC 70377-090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2-mg-desiflex-label-carton.jpg (2 mg Carton Desiflex Label)

Box packaging label for Everolimus Tablets for Oral Suspension, 2 mg strength, manufactured by Biocon Pharma Inc. The carton contains 28 tablets, divided into 4 blister cards of 7 tablets each. Instructions emphasize that tablets must be dispersed in water and not swallowed whole, chewed, or crushed. The label includes storage information and a barcode.*

FDA Label Image

2-mg-pealable-foil.jpg (2 mg Pealable Foil)

Everolimus tablet for oral suspension 2 mg label by Biocon Pharma Inc. The label includes storage instructions (20°C to 25°C with allowed excursions), USP Controlled Room Temperature advisory, lot number and expiration date placeholders, and manufacturing details for Biocon Pharma Inc. in the USA and Biocon Pharma Limited, Bengaluru, India. The label features barcodes and the Biocon logo.*

FDA Label Image

3-mg-desiflex-label-carton.jpg (3 mg Carton Desiflex Label)

Everolimus Tablets for Oral Suspension 3 mg packaging label by Biocon Pharma Inc. The box contains 28 tablets, divided into 4 blister cards of 7 tablets each. Directions state tablets must be dispersed in water and not swallowed whole. The label provides storage conditions and manufacturer details with NDC 70377-091-23.*

FDA Label Image

3-mg-pealable-foil.jpg (3 mg Pealable Foil)

Packaging label for Everolimus tablet for oral suspension 3 mg, manufactured by Biocon Pharma Inc. The label includes storage instructions, dosage strength, NDC 70377-091-23, and the Biocon logo. It also notes Rx only status, lot number and expiration date placeholders, and manufacturer details for Biocon Pharma Inc., based in the USA and India.*

FDA Label Image

5-mg-desiflex-label-carton.jpg (5 mg Carton Desiflex Label)

Packaging label for Everolimus Tablets for Oral Suspension, 5 mg strength, by Biocon Pharma Inc. The carton contains 28 tablets in four blister cards of seven tablets each. The label includes storage instructions, dosage form, oral route, and a statement that tablets must be dispersed in water and not swallowed whole, chewed, or crushed. The NDC is 70377-092-23.*

FDA Label Image

5-mg-pealable-foil.jpg (5 mg Pealable Foil)

Packaging labels for Everolimus tablet for oral suspension 5 mg by Biocon Pharma Inc. The labels show storage instructions, barcodes, and placeholders for lot number and expiration date. The labeler information includes Biocon Pharma Inc. in the USA and Biocon Pharma Limited in India. The design features the Biocon logo and the notation 'Rx only.'*

FDA Label Image

Cont-label-2mg (Cont Label 2mg)

Label for Everolimus Tablets for Oral Suspension 2 mg by Biocon Pharma Inc. The label indicates each tablet contains 2 mg of everolimus USP and must be dispersed in water, not swallowed whole, chewed, or crushed. It includes handling and storage instructions and contact information, plus manufacturing details for Biocon Pharma Limited, Bengaluru, India, and Biocon Pharma, Iselin, NJ, USA. The package contains 28 tablets.*

FDA Label Image

Cont-label-3mg (Cont Label 3mg)

Label for Everolimus Tablets for Oral Suspension 3 mg, containing 28 tablets to be dispersed in water and not swallowed whole. Manufactured by Biocon Pharma Limited, Bengaluru, India, and for Biocon Pharma Inc., Iselin, NJ, USA. Includes storage instructions and a barcode.*

FDA Label Image

Cont-label-5mg (Cont Label 5mg)

The packaging label for Everolimus Tablets for Oral Suspension 5 mg, oral tablets to be dispersed in water and not swallowed whole. It contains 28 tablets and is labeled for prescription use only. The label shows storage instructions, manufacturer as Biocon Pharma Ltd., and the labeler as Biocon Pharma Inc.*

FDA Label Image

Image-01 (Image 01)

Instructional diagram depicting the process of removing individual tablets from a blister pack with scissors and the twisting off of a bottle cap, likely related to handling or preparing oral suspension tablets of Everolimus.*

FDA Label Image

Image-02 (Image 02)

Instructional illustration showing how to cut a blister pack along a marked line using scissors and how to twist open a bottle cap, using numbered arrows indicating the steps to open the medication container.*

FDA Label Image

Image-04 (Image 04)

Chemical structure of Everolimus, showing its complex macrocyclic lactone ring with multiple oxygen and carbon atoms, hydroxyl groups, and an extended side chain typical of this immunosuppressant drug molecule.*

FDA Label Image

Image-05 (Image 05)

Illustration of a syringe labeled with parts including the tip, volume indicators on the barrel, the barrel itself, and the plunger. The diagram emphasizes the components of the syringe used for measuring and dispensing liquid medication.*

FDA Label Image

Image-06 (Image 06)

An illustration showing a pair of hands being washed under running water from a faucet. The image depicts the act of handwashing with soap bubbles visible on the hands.*

FDA Label Image

Image-07 (Image 07)

An instructional illustration showing a hand putting on a disposable glove, commonly used for hygiene and safety during medication preparation or administration.*

FDA Label Image

Image-08 (Image 08)

An instructional illustration showing two views of an oral syringe designed for measuring and administering doses in milliliters, with graduations marked from 1 mL to 10 mL. The syringe is intended for use with oral liquid medications.*

FDA Label Image

Image-10 (Image 10)

An instructional diagram showing a hand placing a tablet into a small bottle, with an arrow indicating the tablet being dropped inside. The illustration likely demonstrates how to prepare a tablet for suspension.*

FDA Label Image

Image-11 (Image 11)

An instructional illustration showing a gloved hand holding a small container or tube open while another gloved hand is dropping a liquid dropper or pipette containing a liquid drop above the opening. The image likely depicts preparation or handling steps for a medication, emphasizing sterile technique.*

FDA Label Image

Image-12 (Image 12)

Black and white instructional illustration showing a hand holding a syringe or oral dosing syringe with markings visible along the barrel. The illustration highlights the plunger being pushed inward, indicated by an arrow pointing toward the syringe tip.*

FDA Label Image

Image-13 (Image 13)

An instructional illustration showing hands preparing an oral suspension by injecting liquid from a syringe into a glass containing tablet(s) that are dissolving. The image demonstrates the mixing process for the Everolimus tablet for suspension oral dosage form.*

FDA Label Image

Image-14 (Image 14)

An instructional diagram showing a hand holding a syringe with a plunger being pulled to draw liquid. A close-up inset highlights air bubbles inside the syringe, emphasizing the need to remove air before use.*

FDA Label Image

Image-15 (Image 15)

An instructional illustration showing a syringe placed inside a glass with liquid, alongside a clock indicating 3 minutes. This likely depicts a step involving mixing or suspending a tablet orally with a waiting time of 3 minutes before use.*

FDA Label Image

Image-16 (Image 16)

An instructional illustration showing two hands holding a syringe-like tablet suspension form of Everolimus. The image demonstrates shaking or mixing the suspension by moving the syringe up and down five times, indicated by an arrow and the text '5 times.' This is to ensure proper mixing before administration.*

FDA Label Image

Image-17 (Image 17)

Illustration showing a hand holding a syringe with the plunger being pulled upwards, likely demonstrating how to draw or prepare a dose from a tablet for suspension formulation of Everolimus oral medication.*

FDA Label Image

Image-18 (Image 18)

An instructional illustration showing a hand administering an oral suspension using a syringe into a person's mouth. The image demonstrates the proper technique for giving Everolimus oral suspension tablets.*

FDA Label Image

Image-19 (Image 19)

An instructional illustration showing the preparation of Everolimus tablet for suspension by drawing water into a syringe to mix with the tablet inside a glass, indicating the process of dissolving the medication for oral administration.*

FDA Label Image

Image-20 (Image 20)

An instructional illustration showing a hand operating a syringe or similar device. The smaller inset highlights air being pushed out from the tip of the syringe, indicating a step to expel air bubbles before administration.*

FDA Label Image

Image-21 (Image 21)

An instructional illustration showing a hand holding a syringe-like device, with an arrow indicating a twisting motion to be performed on the top part of the device. This likely demonstrates a step in preparing or mixing the Everolimus oral suspension tablet before use.*

FDA Label Image

Image-22 (Image 22)

An instructional illustration showing a hand holding a syringe-like device upright with an arrow pointing upwards, indicating the need to pull or lift the plunger. The image likely demonstrates part of the process to prepare or measure liquid medication for oral suspension.*

FDA Label Image

Image-23 (Image 23)

An instructional black-and-white illustration showing a hand holding a syringe-style oral dosing device, administering liquid medication into an open mouth. The image demonstrates the correct method to give an oral suspension dose by syringe.*

FDA Label Image

Image-24 (Image 24)

An instructional illustration showing hands being washed under a running faucet with water flow. Soap bubbles are visible on the hands, indicating the handwashing process.*

FDA Label Image

Image-25 (Image 25)

An instructional illustration showing a hand wearing a protective glove. The image depicts the process of pulling the glove over the wrist.*

FDA Label Image

Image-26 (Image 26)

An illustration showing a 30 mL measuring cup with volume markings at 5 mL, 10 mL, 20 mL, and 30 mL. A line indicates the 25 mL level, accompanied by the text '25 mL of water,' likely instructing the user to measure this amount of water.*

FDA Label Image

Image-27 (Image 27)

An instructional illustration showing a hand wearing a glove pouring a liquid from a small container into a glass. The image likely depicts preparation steps for an oral suspension medication, such as Everolimus tablets for suspension, but contains no text or branding.*

FDA Label Image

Image-29 (Image 29)

An instructional illustration showing a hand placing a tablet into a glass of water, with a downward arrow indicating the tablet is being dropped into the liquid, likely demonstrating preparation of a tablet for suspension.*

FDA Label Image

Image-30 (Image 30)

An illustration showing a tablet dissolving in a glass of liquid next to a clock indicating a time duration of 3 minutes, suggesting the tablet is for suspension before administration.*

FDA Label Image

Image-31 (Image 31)

An illustration showing a hand stirring a tablet in a glass of liquid with a spoon, likely demonstrating the preparation of Everolimus oral suspension tablets for administration.*

FDA Label Image

Image-32 (Image 32)

An illustration showing a side view of a person drinking a liquid from a glass. The image appears instructional, likely demonstrating the administration of an oral medication suspension.*

FDA Label Image

Image-33 (Image 33)

An instructional illustration showing a hand stirring a tablet dissolving in a glass of liquid, likely demonstrating preparation of Everolimus oral suspension tablets before administration.*

FDA Label Image

Image-34 (Image 34)

An instructional line drawing depicting a person drinking from a glass. The image focuses on the side profile of the face and the hand holding the glass, illustrating the act of oral administration of a liquid.*

FDA Label Image

Image-35 (Image 35)

An illustration showing a water faucet dripping water, a glass, and a spoon placed on a surface, likely depicting preparation steps for oral suspension.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.